COPENHAGEN, Denmark, November 6, 2025 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing ...

Learn more about whether MKS Inc. or Teradyne, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Learn more about whether Credo Technology Group Holding Ltd or MKS Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Evaxion Biotech A/S Adr ( ($EVAX) ) has released its Q3 earnings. Here is a breakdown of the information Evaxion Biotech A/S Adr presented to its ...

New Zealand’s welfare system is facing growing strain from rising mental distress, particularly among younger people - many ...

An Auckland man who tried to fraudulently claim more than $2 million has been sentenced to four years and four-and-a-half ...

MSD and Moderna have kicked off another phase 3 trial of their personalised cancer vaccine V940 used alongside MSD's PD-1 inhibitor Keytruda, this time focusing on patients with earlier-stage ...

MSD is reported to have been negotiating with Swiss biotech MoonLake Immunotherapeutics over a takeover deal – estimated to be worth more than $3 billion – according to media reports. The Financial ...